Vanguard Group’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-4,667,786
| Closed | -$31.1M | – | 4525 |
|
|
2023
Q3 | $31.1M | Buy |
4,667,786
+212,433
| +5% | +$1.42M | ﹤0.01% | 2357 |
|
|
2023
Q2 | $40.4M | Buy |
4,455,353
+27,568
| +0.6% | +$250K | ﹤0.01% | 2284 |
|
|
2023
Q1 | $32.2M | Buy |
4,427,785
+35,862
| +0.8% | +$261K | ﹤0.01% | 2383 |
|
|
2022
Q4 | $32M | Buy |
4,391,923
+516,601
| +13% | +$3.77M | ﹤0.01% | 2389 |
|
|
2022
Q3 | $30M | Buy |
3,875,322
+426,617
| +12% | +$3.3M | ﹤0.01% | 2434 |
|
|
2022
Q2 | $23.5M | Buy |
3,448,705
+248,490
| +8% | +$1.69M | ﹤0.01% | 2564 |
|
|
2022
Q1 | $25.5M | Buy |
3,200,215
+1,774,040
| +124% | +$14.1M | ﹤0.01% | 2638 |
|
|
2021
Q4 | $7.99M | Sell |
1,426,175
-33,402
| -2% | -$187K | ﹤0.01% | 3348 |
|
|
2021
Q3 | $11.2M | Buy |
+1,459,577
| New | +$11.2M | ﹤0.01% | 3172 |
|